IPG Health's 'Trial for #ClinicalEquality' campaign continues to run as the agency rolls out a new trial diversity offering for pharma clients.

IPG Health de­buts new clin­i­cal tri­al di­ver­si­ty ap­proach based on ex­pe­ri­ence and spurred by phar­ma re­quests

IPG Health is aim­ing to boost the call for more di­ver­si­ty in clin­i­cal tri­als with a new mul­ti-dis­ci­pli­nary ap­proach for phar­ma clients.

Based on its years of health eq­ui­ty ex­pe­ri­ence — in­clud­ing its on­go­ing “Tri­al for #Clin­i­calE­qual­i­ty” cam­paign — the phar­ma and health­care agency’s lat­est of­fer­ing aims to ad­dress the gap be­tween the de­sire for di­ver­si­ty in clin­i­cal tri­als and the re­al-world lack of it. Phar­ma clients have ap­proached the agency, not­ing its pro bono work and ac­cu­mu­lat­ed ex­per­tise, to ask for help with their own ef­forts.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.